MedTech Dive February 23, 2022
MedTech Dive spoke with diabetes technology leaders about what to expect in 2022, the impact of new products and the increasingly competitive market.
From product launches to companies expanding into new markets and patient populations, diabetes technology companies are poised for another big year in 2022.
Growth in the market already was strong last year as the adoption of continuous glucose monitors and insulin pumps continued to climb. At the same time, the space overall was fairly resilient to the impact of the pandemic whereas other medtechs saw their businesses take a hit.
While companies currently are feeling more pressure from COVID-19 than over the last two years, they are...
Today's Sponsors
Today's Sponsor